Home/Dependencies/Products/IVD Reagents (Biochemical, Immunoassay)

IVD Reagents (Biochemical, Immunoassay)

High dependencyBuild-nowMedical DevicesReasoned estimateHS 3822.00
$0.50 bnAnnual import
30%Indian capability
3,725Supplier concentration (HHI)
₹1,500 crTo localise

Why India imports it. Roche, Abbott, Siemens Healthineers dominate; Transasia, Bayer India growing.

Why it matters. Diagnostics backbone; pandemic exposed import risk.

Can India localise it? Yes - 3-5 years for biochemistry reagents.

Where it comes from. USA (50%), Germany (30%), Switzerland (15%).

Scorecard

The ten indices

CMDI 71.25Dependency
LPI 53Localisation potential
IAI 59.75Investment attractiveness
SRI 63.25Supply risk
SCI 55.25Supply-chain complexity
TRI 38.75Technology readiness
IMI 67Industrial multiplier
NSRI 58.25National-security relevance
EPI 59.5Export potential
ICGI 65.5Capability gap
Who makes it

Manufacturers

In India

Transasia Bio-MedicalsVista Clinical Systems

Global leaders

Roche DiagnosticsAbbott DiagnosticsSiemens Healthineers

Intelligence

Related signals

Sources

Primary references

Confidence: Reasoned estimate. Reasoned estimate. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).